{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:44:17Z","timestamp":1787582657203,"version":"build-2736575974"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Prostate cancer (PCa) is one of the most common malignancies in men worldwide, and its development is influenced by multiple factors, including genetic susceptibility, hormonal dysregulation, chronic inflammation, immune dysregulation, and remodeling of the tumor microenvironment. In recent years, the urinary tract microbiome has emerged as an important component of the tumor ecosystem and has attracted increasing attention in PCa research. Accumulating evidence indicates that patients with PCa exhibit characteristic microbial alterations in urine, expressed prostatic secretions, semen, and prostate tissue, and that certain taxa are associated with tumor grade, stage, and recurrence risk. These microbes may participate in tumor initiation and progression through a variety of mechanisms, such as inducing chronic inflammation, activating signaling pathways including TLR\/NF-\u03baB and STAT3, modulating the Treg\/Th17 balance, influencing macrophage polarization, and interfering with androgen metabolism. Meanwhile, advances in 16S rRNA sequencing, metagenomics, metatranscriptomics, and multi-omics integration have provided powerful tools for characterizing host\u2013microbe interactions and their functional relevance. In addition, microbiome-based biomarkers derived from non-invasive samples such as urine, together with artificial intelligence and causal inference approaches applied to multi-cohort data, may offer promising opportunities for early screening, risk stratification, treatment monitoring, and personalized intervention in PCa. However, current evidence remains largely associative, and the causal relationship between microbial changes and PCa has not yet been fully established. Major challenges, including contamination in low-biomass samples and inter-cohort heterogeneity, continue to hinder clinical translation. Future research should focus on longitudinal cohort studies, multicenter validation, standardized sampling workflows, and mechanistic experiments to clarify key microbial signatures and their biological functions, thereby accelerating the clinical application of the urinary tract microbiome in precision diagnosis and treatment of PCa.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1911969","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:11:15Z","timestamp":1787580675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Research progress and clinical translation prospects of the urinary tract microbiome in prostate cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Ze-lin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-nan","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-xuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shenzhen Hospital, Southern Medical University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70020","article-title":"The contemporary management of prostate cancer","volume":"75","author":"Chakrabarti","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.(2025).0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70028","article-title":"Prostate cancer statistics, 2025","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"Jama"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.(2025).3386","article-title":"Prostate-specific antigen levels among participants receiving annual testing","volume":"11","author":"Pickersgill","year":"2025","journal-title":"JAMA Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.11.003","article-title":"Population-based screening for prostate cancer: is it time","volume":"87","author":"Hugosson","year":"2025","journal-title":"Eur Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.0455","article-title":"Development and validation of an 18-gene urine test for high-grade prostate cancer","volume":"10","author":"Tosoian","year":"2024","journal-title":"JAMA Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41391-024-00840-0","article-title":"Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer","volume":"28","author":"Robinson","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12943-024-02137-1","article-title":"Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota","volume":"23","author":"Chen","year":"2024","journal-title":"Mol Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05852-11","article-title":"Evidence of uncultivated bacteria in the adult female bladder","volume":"50","author":"Wolfe","year":"2012","journal-title":"Clin Microbiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02876-13","article-title":"Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder","volume":"52","author":"Hilt","year":"2014","journal-title":"Clin Microbiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1576679","article-title":"Advances in human microbiome and prostate cancer research","volume":"16","author":"Pei","year":"2025","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2024.12.005","article-title":"The human urinary microbiome and its potential role in urinary tract infections","volume":"10","author":"Saenz","year":"2024","journal-title":"Eur Urol Focus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1186\/s12866-025-04455-w","article-title":"XGBoost-based urinary microbial signatures enable non-invasive diagnosis and prognosis for urothelial carcinoma","volume":"25","author":"Xie","year":"2025","journal-title":"BMC Microbiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1728182","article-title":"Research advances on the urinary microbiome in non-infectious urinary tract diseases: from community composition to clinical prospects","volume":"16","author":"Zhang","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41579-024-01092-4","article-title":"Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics","volume":"23","author":"Timm","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-024-01520-x","article-title":"Current trends and challenges of microbiome research in prostate cancer","volume":"26","author":"Trecarten","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1512891","article-title":"Exploring urinary microbiome: insights into neurogenic bladder and improving management of urinary tract infections","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23713","article-title":"A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16S rRNA gene analysis","volume":"79","author":"Alanee","year":"2019","journal-title":"Prostate"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2022.03.006","article-title":"Microbiomes of urine and the prostate are linked to human prostate cancer risk groups","volume":"5","author":"Hurst","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1699308","article-title":"Deciphering the urinary microbiome and urological cancers: from correlation to mechanisms and treatment","volume":"16","author":"Zheng","year":"2025","journal-title":"Front Microbiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17233841","article-title":"Genitourinary microbiome and volatilome: a pilot study in patients with prostatic adenocarcinoma submitted to radical prostatectomy","volume":"17","author":"Musleh","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1690498","article-title":"Reprogramming prostate cancer through the microbiome","volume":"12","author":"Bautista","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01664","article-title":"The microbiome of prostate fluid is associated with prostate cancer","volume":"10","author":"Ma","year":"2019","journal-title":"Front Microbiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.03.029","article-title":"The microbiome of the prostate tumor microenvironment","volume":"72","author":"Cavarretta","year":"2017","journal-title":"Eur Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1562729","article-title":"Prostate and urinary microbiomes in prostate cancer development: focus on Cutibacterium acnes","volume":"15","author":"Fu","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030212","article-title":"Mycoplasma genitalium infection and chronic inflammation in human prostate cancer: detection using prostatectomy and needle biopsy specimens","volume":"8","author":"Miyake","year":"2019","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086939","article-title":"Human male genital tract microbiota","volume":"24","author":"Zuber","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00432-025-06187-w","article-title":"Microbiome in prostate cancer: pathogenic mechanisms, multi-omics diagnostics, and synergistic therapies","volume":"151","author":"Wang","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168943","article-title":"Different prostatic tissue microbiomes between high- and low-grade prostate cancer pathogenesis","volume":"25","author":"Kim","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13073-022-01011-3","article-title":"Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling","volume":"14","author":"Salachan","year":"2022","journal-title":"Genome Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5173\/ceju.2024.80","article-title":"Genitourinary microbiomes and prostate cancer: a systematic review and meta-analysis of tumorigeneses and cancer characteristics","volume":"77","author":"Parizi","year":"2024","journal-title":"Cent Eur J Urol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081929","article-title":"Association of intratumoral microbiota modulation with prostate cancer progression: a microbiome analysis of prostatic tissue","volume":"13","author":"Kim","year":"2025","journal-title":"Biomedicines"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.894777","article-title":"Differential microbial signature associated with benign prostatic hyperplasia and prostate cancer","volume":"12","author":"Sarkar","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13027-016-0074-9","article-title":"Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer","volume":"9","author":"Davidsson","year":"2016","journal-title":"Infect Agent Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/med.70042","article-title":"Urologic bacteriome: the hero or the villain in prostate cancer onset, progression, and treatment","volume":"46","author":"Fonseca","year":"2026","journal-title":"Med Res Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-022-00602-w","article-title":"Urinary microbiota and prostatic diseases: the key for the lock? A systematic review","volume":"26","author":"Mjaess","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051423","article-title":"Microbiota of urine, glans and prostate biopsies in patients with prostate cancer reveals a dysbiosis in the genitourinary system","volume":"15","author":"Gon\u00e7alves","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24763","article-title":"A prospective evaluation of the prostate microbiome in Malignant and benign tissue using transperineal biopsy","volume":"84","author":"Chen","year":"2024","journal-title":"Prostate"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1048319","article-title":"Localization and potential role of prostate microbiota","volume":"12","author":"Okada","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01255-4","article-title":"Guideline for designing microbiome studies in neoplastic diseases","volume":"46","author":"Mik\u00f3","year":"2024","journal-title":"Geroscience"},{"key":"B44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ccell.2026.02.011","article-title":"Toward a consensus on the tumor microbiota: evidence, standards, and interpretation","volume":"44","author":"Duan","year":"2026","journal-title":"Cancer Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2021.09.012","article-title":"Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections","volume":"38","author":"Diao","year":"2021","journal-title":"J Adv Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23897","article-title":"Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African men","volume":"79","author":"Feng","year":"2019","journal-title":"Prostate"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-021-00413-5","article-title":"The microbiome and prostate cancer","volume":"25","author":"Javier-DesLoges","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-0503","article-title":"A prospective study of chronic inflammation in benign prostate tissue and risk of prostate cancer: linked PCPT and SELECT cohorts","volume":"26","author":"Platz","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.11499","article-title":"Prostatitis: a review","volume":"334","author":"Borgert","year":"2025","journal-title":"Jama"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13020315","article-title":"The urogenital system microbiota: is it a new gamechanger in urogenital cancers","volume":"13","author":"Ece","year":"2025","journal-title":"Microorganisms"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59030483","article-title":"The association of prostate cancer and urinary tract infections: a new perspective of prostate cancer pathogenesis","volume":"59","author":"Pan","year":"2023","journal-title":"Med (Kaunas)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13099-016-0103-7","article-title":"Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples","volume":"8","author":"Glassing","year":"2016","journal-title":"Gut Pathog"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168849","article-title":"Prostate infiltration by Treg and Th17 cells as an immune response to Propionibacterium acnes infection in the course of benign prostatic hyperplasia and prostate cancer","volume":"23","author":"Radej","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/biology15010030","article-title":"Cutibacterium acnes: an emerging prostate cancer pathogen","volume":"15","author":"Brajdic","year":"2025","journal-title":"Biology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24723","article-title":"Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer","volume":"84","author":"Ashida","year":"2024","journal-title":"Prostate"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22648","article-title":"A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes","volume":"73","author":"Shinohara","year":"2013","journal-title":"Prostate"},{"key":"B57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13046-021-02196-y","article-title":"Dysbiotic microbes and how to find them: a review of microbiome profiling in prostate cancer","volume":"41","author":"Salachan","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.052012","article-title":"Prostatic Escherichia coli infection drives CCR2-dependent recruitment of fibrocytes and collagen production","volume":"18","author":"Scharpf","year":"2025","journal-title":"Dis Model Mech"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12035","article-title":"Propionibacterium acnes activates caspase-1 in human neutrophils","volume":"121","author":"Sahdo","year":"2013","journal-title":"APMIS"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01497-21","article-title":"Cutibacterium acnes induces the expression of immunosuppressive genes in macrophages and is associated with an increase of regulatory T-cells in prostate cancer","volume":"9","author":"Davidsson","year":"2021","journal-title":"Microbiol Spectr"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102374","article-title":"3-acetyl-11-keto-\u03b2-boswellic acid and chitosan-Ag nanoparticles for synergistic tumor-resident bacteria mediated prostate cancer therapy","volume":"35","author":"Zou","year":"2025","journal-title":"Mater Today Bio"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae120","article-title":"BATF-dependent Th17 cells act through the IL-23R pathway to promote prostate adenocarcinoma initiation and progression","volume":"116","author":"Liu","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.935806","article-title":"PD-L1 up-regulation in prostate cancer cells by Porphyromonas gingivalis","volume":"12","author":"Groeger","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.606986","article-title":"Lipopolysaccharide preparation derived from Porphyromonas gingivalis induces a weaker immuno-inflammatory response in BV-2 microglial cells than Escherichia coli by differentially activating TLR2\/4-mediated NF-\u03baB\/STAT3 signaling pathways","volume":"11","author":"Qiu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1186\/s12967-025-07234-3","article-title":"Mechanistic insights into SLAMF8-mediated prostate cancer metastasis via the TLR4-NF-\u03baB pathway","volume":"23","author":"Su","year":"2025","journal-title":"J Transl Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03169-z","article-title":"IL-17RA\/CTSK axis mediates H. pylori-induced castration-resistant prostate cancer growth","volume":"43","author":"Lin","year":"2024","journal-title":"Oncogene"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-080719-091604","article-title":"Microbiota effects on carcinogenesis: initiation, promotion, and progression","volume":"72","author":"Lopez","year":"2021","journal-title":"Annu Rev Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41579-025-01237-z","article-title":"Fusobacterium nucleatum: ecology, pathogenesis and clinical implications","volume":"24","author":"Jiang","year":"2026","journal-title":"Nat Rev Microbiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.755764","article-title":"Cytotopic (Cyto-) IL-15 as a new immunotherapy for prostate cancer: recombinant production in Escherichia coli and purification","volume":"8","author":"Esteves","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2018976118","article-title":"Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer","volume":"118","author":"Shrestha","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.10.015","article-title":"Colibactin exerts androgen-dependent and -independent effects on prostate cancer","volume":"8","author":"Agrawal","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.molmed.2025.03.015","article-title":"New insights into gut microbiota-prostate cancer crosstalk","volume":"31","author":"Laaraj","year":"2025","journal-title":"Trends Mol Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S332943","article-title":"Bacterial lipopolysaccharide augmented Malignant transformation and promoted the stemness in prostate cancer epithelial cells","volume":"14","author":"Tang","year":"2021","journal-title":"J Inflammation Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-01996-8","article-title":"Linking bacterial androgen production and prostate cancer","volume":"10","author":"Arp","year":"2025","journal-title":"Nat Microbiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/ph17010112","article-title":"Microbiome and prostate cancer: emerging diagnostic and therapeutic opportunities","volume":"17","author":"Kim","year":"2024","journal-title":"Pharm (Basel)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/biom16020271","article-title":"Challenges and opportunities in multi-omics data acquisition and analysis: toward integrative solutions","volume":"16","author":"Hemme","year":"2026","journal-title":"Biomolecules"},{"key":"B77","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-026-02658-x","article-title":"The evolving role of OMICS in gastrointestinal tumor biology and clinical practice","volume":"25","author":"Li","year":"2026","journal-title":"Mol Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18081219","article-title":"Microbial genomic consortia in prostate cancer: mechanistic signaling, the gut-prostate axis, and translational perspectives","volume":"18","author":"P\u00e9rez-Campos Mayoral","year":"2026","journal-title":"Cancers (Basel)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2026.121086","article-title":"Circulating microbial metabolites and the gut-prostate axis in prostate cancer: implications for laboratory biomarkers and therapeutic response","volume":"590","author":"Tan","year":"2026","journal-title":"Clin Chim Acta"},{"key":"B80","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.prnil.2024.11.004","article-title":"Sex hormones, blood metabolites and proteins mediating the causal associations between gut microbiota and prostatic diseases: evidences from Mendelian randomization study","volume":"13","author":"Liu","year":"2025","journal-title":"Prostate Int"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-335946","article-title":"AI-empowered human microbiome research","volume":"75","author":"Zhou","year":"2026","journal-title":"Gut"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-02035-2","article-title":"Guidelines for preventing and reporting contamination in low-biomass microbiome studies","volume":"10","author":"Fierer","year":"2025","journal-title":"Nat Microbiol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01552-x","article-title":"Reporting guidelines for human microbiome research: the STORMS checklist","volume":"27","author":"Mirzayi","year":"2021","journal-title":"Nat Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-025-01028-w","article-title":"The role of the human microbiome in prostate cancer: a systematic review from diagnosis to treatment","author":"Distante","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/mrc.5391","article-title":"Differentiation of patients with and without prostate cancer using urine \u00b9H NMR metabolomics","volume":"61","author":"Hasubek","year":"2023","journal-title":"Magn Reson Chem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0029-9","article-title":"Best practices for analysing microbiomes","volume":"16","author":"Knight","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063291","article-title":"Microbiome dysbiosis is associated with castration resistance and cancer stemness in metastatic prostate cancer","volume":"25","author":"Uzelac","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-023-00795-2","article-title":"The potential role of the microbiota in prostate cancer pathogenesis and treatment","volume":"20","author":"Pernigoni","year":"2023","journal-title":"Nat Rev Urol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s41467-018-03900-x","article-title":"Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy","volume":"9","author":"Anker","year":"2018","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2626","article-title":"Live biotherapeutic products as cancer treatments","volume":"83","author":"Brevi","year":"2023","journal-title":"Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1911969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:11:17Z","timestamp":1787580677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1911969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":90,"alternative-id":["10.3389\/fimmu.2026.1911969"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1911969","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1911969"}}